Olivier BYLICKI
HIA Sainte Anne / Groupe Français d'Onco-Pneumologie
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Olivier BYLICKI as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 07:23 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT06552234 · Phase II Efficacy Study of Repotrectinib in Frail and/or Elderly Patients With ROS1-rearranged Advanced NSCLCCentre Hospitalier Intercommunal de Toulon La Seyne sur Mer · recruiting · NSCLC Stage IV, NSCLC, Stage III · study director
Grants
NIH projects from RePORTER, fetched 2026-11-12 07:23 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 07:23 UTC. The ranking covers the 200 most relevant of 16 PubMed records, and a shared surname and initials can bring in a namesake. All 16 on PubMed
- Perioperative Pembrolizumab for Early-Stage Non-Small-Cell Lung Cancer.N Engl J Med · 20231,104 citationsRCR 94.7
- 368 citationsRCR 13.3
- 320 citationsRCR 34.5
- Stay and play eFAST or scoop and run eFAST? That is the question!Am J Emerg Med · 201443 citationsRCR 2.8
- Five-Year Outcomes of Perioperative Pembrolizumab for Early-Stage Non-Small-Cell Lung Cancer From the Randomized KEYNOTE-671 Study.Ann Oncol · 202643 citationsRCR 21.5
- 41 citationsRCR 6.5
- 28 citationsRCR 2.1
- 23 citationsRCR 4.6
- 18 citationsRCR 3.8
- Performances, feasibility and acceptability of nasopharyngeal swab, saliva and oral-self sampling swab for the detection of severe acute respiratory syndrome coronavirus 2.Eur J Clin Microbiol Infect Dis · 202115 citationsRCR 1.0